ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -75.0% | 300 | -70.0% | 0.00% | – |
| Q2 2022 | $8,000 | -42.9% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $14,000 | -50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $28,000 | -17.6% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -17.1% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $41,000 | +46.4% | 1,000 | +42.9% | 0.00% | +100.0% |
| Q1 2021 | $28,000 | -15.2% | 700 | +2.0% | 0.00% | -50.0% |
| Q2 2020 | $33,000 | – | 686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |